Data protection Impressum

Gene Therapy

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded CHF 50,000 grants to three academic spin-off projects from Geneva, supporting innovation in medical technology, scientific instrumentation, and gene therapy.

FIF awards grants to three Geneva-based academic spin-offs

29 January 2026

The FIF has once again highlighted its commitment to propelling tech innovation in Geneva by awarding significant financial support to three promising projects.

Azure Cell Therapies, FireFly Fusion and Antion Biosciences receive FIF support

29 April 2024

NewBiologix pioneers breakthrough gene therapies with USD 50 million investment

16 May 2023

University of Bern spin-off Arctos Medical acquired by Novartis

22 September 2021

Scaling global biologics production: partnerships across the value chain

5 November 2020

JSR Life Sciences to expand KBI Biopharma and Selexis’ biologics manufacturing capabilities in Geneva

22 October 2020

GE Healthcare to build new manufacturing facility in Switzerland

30 January 2020